Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Total Liabilities: 2016-2024

Historic Total Liabilities for Collegium Pharmaceutical (COLL) over the last 9 years, with Dec 2024 value amounting to $1.4 billion.

  • Collegium Pharmaceutical's Total Liabilities fell 4.88% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 4.88%. This contributed to the annual value of $1.4 billion for FY2024, which is 51.36% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Total Liabilities stood at $1.4 billion for FY2024, which was up 51.36% from $947.9 million recorded in FY2023.
  • Collegium Pharmaceutical's 5-year Total Liabilities high stood at $1.4 billion for FY2024, and its period low was $457.8 million during FY2020.
  • Over the past 3 years, Collegium Pharmaceutical's median Total Liabilities value was $979.3 million (recorded in 2022), while the average stood at $1.1 billion.
  • In the last 5 years, Collegium Pharmaceutical's Total Liabilities soared by 109.17% in 2020 and then dropped by 3.21% in 2023.
  • Yearly analysis of 5 years shows Collegium Pharmaceutical's Total Liabilities stood at $457.8 million in 2020, then grew by 6.85% to $489.1 million in 2021, then surged by 100.20% to $979.3 million in 2022, then fell by 3.21% to $947.9 million in 2023, then surged by 51.36% to $1.4 billion in 2024.